Nrc Health (NRC) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Nrc Health  (NASDAQ: NRC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Nrc Health's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nrc Health's ROI in the second quarter of 2026?
Nrc Health achieved a return on average invested assets (ROI) of 6 % in its second quarter of 2026, which is below Nrc Health's average return on investment, which stands at 28.32%.

ROI decreased relative to the period ending Mar 31 2026, due to the decline in net income.

Within the Healthcare sector 28 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 931, from total ROI ranking in the first quarter of 2026 at 953.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 1.46 % 11.12 % 21.63 % 23.01 % 26.12 %
Y / Y Net Income Change TTM -67.45 % -62.68 % -37.04 % 37.94 % 190.36 %
Investment (TTM) in Millions 101 96 98 94 102
Return On Investment (TTM) 6 % 9.27 % 11.86 % 16.79 % 18.7 %
NRC's Overall Ranking # 931 # 953 # 589 # 273 # 301
Seq. Investment Change TTM -0.21 % -0.34 % 0.4 % 1.61 % 9.29 %
Seq. Net Income Change TTM -35.4 % -22.11 % -29.11 % -8.73 % -25.94 %
Net Income (TTM) in Millions 6 9 12 16 18




Return On Investment NRC's Ranking
Within: No.
Industry # 1
Sector # 29
Overall # 931

Return On Investment Statistics
High Average Low
50.47 %
28.32 %
7.83 %
(Mar 31 2020)   (Dec 31 2015)



  News about Nrc Health Return on Investment ROI

National Research Corporation Elevates Leadership Team to Drive Growth Opportunity

January 17, 2024



LINCOLN, Neb. - National Research Corporation, also known as NRC Health (NASDAQ: NRC), has recently made significant leadership changes by creating four executive officer positions. These developments come as the company aims to capitalize on growth opportunities in the market.
Helen Hrdy, an esteemed leader at NRC Health, has been promoted to the crucial role of Chief Customer Officer. This elevation signifies an expansion of her responsibilities within the organization. As the newly appointed Chief Customer Officer, Hrdy will play a pivotal role in strengthening customer relationships, establishing strategic alliances, and enhancing overall customer satisfaction.






Financial Statements
Nrc Health's II. Quarter Investments $ 101 Millions NRC's Balance sheet
Nrc Health's II. Quarter Income $ -3 Millions Quarterly NRC's Income Statement
NRC's Income by Division See NRC's Income by Division


NRC Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 92 97 82 92 110
Y / Y Investment Growth -4.56 % 17.77 % -10.54 % -16.69 % 16.59 %
Net Income in Millions 12 25 31 32 37
Y / Y Net Income Growth -53.19 % -19.98 % -2.61 % -15.12 % 0.55 %
Annual Return On Investment 12.57 % 25.63 % 37.73 % 34.65 % 34.01 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 12.57 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NRC's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NRC's Competitors
Subscribers only: Roi for Nrc Health's Suppliers
Subscribers only: Return On Investment for NRC's Customers

Other Ratios
NRC's Roa NRC's Inventory Turnover Ratio NRC's Growth Rates NRC's Dividend Statistics
NRC's Profitability Ratios NRC's Asset Turnover Ratio NRC's Dividend Growth
NRC's Roe NRC's Valuation Ratios NRC's Financial Strength Ratios NRC's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %
Aveanna Healthcare Holdings Inc   16.32 %
Harmony Biosciences Holdings inc   15.85 %
Entera Bio Ltd   15.84 %
Nephros Inc   15.31 %
West Pharmaceutical Services Inc   15.29 %
Progyny Inc   15.25 %
Biolife Solutions Inc   14.83 %
Sbc Medical Group Holdings Incorporated  14.78 %
Spero Therapeutics Inc   14.54 %
Insulet Corporation  14.30 %
Alpha Pro Tech Ltd   13.80 %
Bristol myers Squibb Company  13.58 %
Transmedics Group Inc   13.46 %
Strata Critical Medical Inc   13.34 %
Johnson and Johnson  13.30 %
Amgen Inc   13.08 %
Medinotec Inc   13.06 %
Lantheus Holdings Inc   13.02 %
Msa Safety Inc  13.02 %
Universal Health Services Inc   12.43 %
Ufp Technologies Inc   12.12 %
Solventum Corporation  11.98 %
Ligand Pharmaceuticals Incorporated  11.93 %
Lifevantage Corp  11.84 %
Regeneron Pharmaceuticals Inc   11.83 %
Protagonist Therapeutics inc   11.66 %
Encompass Health Corporation  11.56 %
Embecta Corp   11.20 %


Date modified: 2026-09-26T07:05:08+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.